Redica
Redica is an intelligence cloud platform designed to support quality and regulatory teams within life sciences organizations. It transforms complex global regulatory data into clear, actionable intelligence that helps teams stay compliant and proactive. The platform unifies regulatory intelligence, inspection findings, and supplier quality insights into a single connected system. By using explainable AI, Redica enables teams to monitor regulatory changes and understand their impact faster. Its inspection intelligence tools help organizations predict and prepare for audits using global benchmarking data. Redica also provides site and supplier intelligence to manage manufacturing and supply chain risks effectively. Overall, the platform shifts teams away from manual data tracking toward faster, insight-driven compliance decisions.
Learn more
DrugCard
DrugCard is an AI-powered pharmacovigilance platform that helps pharmaceutical companies, CROs, and drug safety teams automate key PV workflows. The platform supports global and local literature monitoring, regulatory intelligence, and adverse event management, helping teams reduce manual screening, identify relevant safety information faster, and maintain audit-ready processes. DrugCard combines AI-driven article pre-assessment, summaries, translations, keyword highlighting, notifications, reporting, audit trails, and case management tools in one connected system. With coverage of 121+ countries, 2,200+ local medical sources, and 100+ languages, DrugCard is designed for MAHs, QPPVs, LQPPVs, regulatory teams, and PV professionals who need scalable, transparent, and compliant automation while keeping human experts in control of final decisions.
Learn more
Dialog
Dialog offers a modular, end-to-end pharmacovigilance literature monitoring solution that supports organizations tasked with drug safety reporting by streamlining and automating the entire literature triage process. It provides access to over 140 authoritative scientific and medical literature databases, such as MEDLINE, Embase, and Biosis, standardizing content across sources to ensure consistent precision search, deduplication, and structured XML output. The DialogML engine employs artificial intelligence to rank search results by patient-safety relevance, highlight key safety concepts, and tag references related to ICSRs (Individual Case Safety Reporting), aggregate reports (PBRER, PSUR, DSUR), and safety signals, so reviewers can rapidly identify high-priority articles. The Dialog Alerts Manager simplifies alert creation and management, offering bulk editing, audit trails of search strategy changes, scheduling flexibility, and delivery history tracking.
Learn more
CoVigilAI
CoVigilAI is an AI-enabled medical literature monitoring solution that employs advanced algorithms and data analytics to proactively detect and manage adverse drug events, ensuring patient safety and regulatory compliance in real time. The platform offers streamlined tracking of scientific and medical publications across prominent global literature databases such as PubMed and Embase, with customizable search strings facilitating an effortless pharmacovigilance literature monitoring journey. Periodic surveillance of scientific and medical literature databases and publications from diverse local journals is conducted, encompassing both global literature monitoring and localized literature surveillance. Advanced algorithms categorize Individual Case Safety Reports (ICSRs) into valid, potential, and invalid cases, while automated key entity detection efficiently recognizes crucial entities like patients, medications, adverse events, and designated medical events.
Learn more